编码肿瘤排斥抗原的基因：特异性免疫疗法的前景 - Suppr

Suppr

超能文献

Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.

作者信息

Boon T, Coulie P, Marchand M, Weynants P, Wölfel T, Brichard V

机构信息

Cellular Genetics Unit, Ludwig Institute for Cancer Research, Brussels, Belgium.

出版信息

Important Adv Oncol. 1994:53-69.

PMID:8206495

Abstract

摘要

相似文献

Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.编码肿瘤排斥抗原的基因：特异性免疫疗法的前景

Important Adv Oncol. 1994:53-69.

Peptide mimics of a tumor antigen induce functional cytotoxic T cells.肿瘤抗原的肽模拟物可诱导功能性细胞毒性T细胞。

Nat Biotechnol. 1998 Mar;16(3):276-80. doi: 10.1038/nbt0398-276.

An HLA-A2 polyepitope vaccine for melanoma immunotherapy.一种用于黑色素瘤免疫治疗的HLA - A2多表位疫苗。

J Immunol. 1999 Oct 1;163(7):4058-63.

The structure and function of MHC molecules. Possible implications for the control of tumor growth by MHC-restricted T cells.MHC分子的结构与功能。MHC限制的T细胞对肿瘤生长控制的潜在影响。

Semin Cancer Biol. 1991 Oct;2(5):275-82.

The potential of melanoma antigen expression in cancer therapy.黑色素瘤抗原表达在癌症治疗中的潜力。

Cancer Treat Rev. 1999 Aug;25(4):219-27. doi: 10.1053/ctrv.1999.0126.

Polymerised autologous tumor tissue particles in experimental cancer immunotherapy with special reference to the effects on the immune system of the host.

Arch Geschwulstforsch. 1980;50(8):724-34.

Tumor immunology.肿瘤免疫学

Immunol Ser. 1990;50:513-33.

IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.在转移经P815AB脉冲处理的树突状细胞后，白细胞介素-12对于启动T细胞对I类限制性肿瘤肽（P815AB）的反应性而言既是必需的也是充分的。

J Immunol. 1996 Aug 15;157(4):1589-97.

Identification of tumor-regression antigens in melanoma.黑色素瘤中肿瘤消退抗原的鉴定。

Important Adv Oncol. 1996:3-21.

[Tumor antigens recognized by T-lymphocytes in human cancers. New advances and therapeutic perspectives].[人类癌症中T淋巴细胞识别的肿瘤抗原。新进展与治疗前景]

Pathol Biol (Paris). 1998 Dec;46(10):771-8.

引用本文的文献

Specific increase in potency via structure-based design of a TCR.通过基于结构的T细胞受体设计实现效力的特异性增强。

J Immunol. 2014 Sep 1;193(5):2587-99. doi: 10.4049/jimmunol.1302344. Epub 2014 Jul 28.

Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy.对接受免疫治疗的癌症患者的抗原特异性细胞毒性T淋巴细胞的监测。

Clin Diagn Lab Immunol. 2000 May;7(3):327-32. doi: 10.1128/CDLI.7.3.327-332.2000.

Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy.自然杀伤细胞系可杀伤自体β2-微球蛋白缺陷的黑色素瘤细胞：对癌症免疫治疗的启示。

Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13140-5. doi: 10.1073/pnas.94.24.13140.

Induction of specific cytotoxic T lymphocytes against autologous brain tumor by crossreactive allo-tumor cell stimulation.通过交叉反应性同种肿瘤细胞刺激诱导针对自体脑肿瘤的特异性细胞毒性T淋巴细胞。

Jpn J Cancer Res. 1997 Mar;88(3):289-95. doi: 10.1111/j.1349-7006.1997.tb00380.x.

Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100.编码人类黑色素瘤抗原MART1和gp100的小鼠同源物的基因的克隆与特性分析。

J Immunother. 1997 Jan;20(1):15-25. doi: 10.1097/00002371-199701000-00002.

Direct identification of tumor-associated peptide antigens.肿瘤相关肽抗原的直接鉴定

Springer Semin Immunopathol. 1996;18(2):171-83. doi: 10.1007/BF00820664.

Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1.针对黑色素瘤相关抗原（MAGE）的基因疫苗和细胞疫苗诱导抗原特异性肿瘤免疫：通过共表达粒细胞-巨噬细胞集落刺激因子（GM-CSF）和B7-1增强肿瘤保护作用

Mol Med. 1996 Sep;2(5):545-55.

Interleukin-7, interleukin-12, and GM-CSF gene transfer in patients with metastatic melanoma.

J Mol Med (Berl). 1995 Sep;73(9):473-7. doi: 10.1007/BF00202266.

Biotherapy of cancer. Perspectives of immunotherapy and gene therapy.癌症的生物疗法。免疫疗法和基因疗法的前景。

J Cancer Res Clin Oncol. 1995;121(8):443-51. doi: 10.1007/BF01218359.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验